Recro Pharma, Inc.

City:

Malvern, Pennsylvania

Country:

United States

Published Applications:

Last publication date:

2018-08-16

Patent Grants:

Last grant date:

2019-11-05

Top Inventors for applications by Recro Pharma, Inc.

These are the the leading inventors for applications assigned to Recro Pharma, Inc.:

Christopher T. Sharr 3 Malvern, PA United States
Tarja Lehtimaki 3 Sauvo, Finland
Riitta Heino 3 Turku, Finland
Tiina Leino 3 Piikkio, Finland

Eugene R. Cooper 2 Berwyn, PA United States
John Pruitt 2 Suwanee, GA United States
Tuula RYDE 2 Malvern, PA United States
Randall J. Mack 2 Paoli, PA United States

Laura Kline 2 Harleysville, PA United States
Geraldine A. Henwood 2 Malvern, PA United States
Recro Pharma, Inc. 1 Malvern, PA United States
John KOLENG 1 Austin, TX United States

Tiina Leino 1 Piikko, Finland
Geraldine Anne Henwood 1 Malvern, PA United States
Randall Jerome Mack 1 Paoli, PA United States
John J. Koleng, JR. 1 Austin, TX United States

Charles Alexander Freyer 1 Glenside, PA United States
John Joseph Koleng, JR. 1 Austin, TX United States

Recent patent applications by Recro Pharma, Inc.

Recro Pharma, Inc. based in Malvern, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2018-08-16 ✅ Patent 10,463,673 granted on 2019-11-05

US20180228809A1

Human necessities

Nanoparticulate meloxicam formulations

#2 | 2017-06-08 ✅ Patent 10,471,067 granted on 2019-11-12

US20170157061A1

Human necessities

Nanoparticulate meloxicam formulations

#3 | 2016-02-04 ✅ Patent 9,446,025 granted on 2016-09-20

US20160030392A1

Human necessities

Treatment or prevention of hypotension and shock

#4 | 2014-04-10 ✅ Patent 9,078,883 granted on 2015-07-14

US20140100257A1

Human necessities

Treatment or prevention of hypotension and shock

#5 | 2013-07-11 ✅ Patent 9,795,559 granted on 2017-10-24

US20130178465A1

Human necessities

Intranasal dexmedetomidine compositions and methods of use thereof

#6 | 2013-03-21

US20130072532A1

Human necessities

TOPICAL TRANSDERMAL DEXMEDETOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF

#7 | 2011-12-01 ✅ Patent 8,470,862 granted on 2013-06-25

US20110294862A1

Human necessities

Treatment or prevention of hypotension and shock

#8 | 2011-01-27

US20110021588A1

Human necessities

SUBLINGUAL DEXMEDITOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF

Also check out Recro Pharma, Inc.'s (Malvern, United States) applicant profile with 5 patent applications submitted.

AssigneeID:

14994 ⎘